| abstract |
Treatment or prevention of overactive bladder or urinary incontinence in mammals, particularly humans, is disclosed using (S)-N-[2-(3,4-dichlorophenyl)-4-[4-(2-oxoperhydropyrimidin-1-yl)piperidino]butyl]-N-methylbenzamide. Pharmaceutically-advantageous salts of the compound, methods of use of the compound, either alone or in combination with other pharmacological agents, and pharmaceutical compositions useful in practising the methods of the invention are also disclosed. |